相关实验视频
Updated: Jun 23, 2025
15:49
Reverse Genetics to Engineer Positive-Sense RNA Virus Variants
Published on: June 9, 2022
1.4K
在中度至重度功能障碍的COVID-19患者中,法维皮拉维尔的药理动力学:经验教训
概括
与健康成年人相比,患有功能障碍的重症COVID-19患者的法维皮拉维尔暴露率较低. 这表明吸收和处置发生了变化,需要进一步的药理动力学研究以获得最佳剂量.
科学领域:
- 药理学 药理学是指药理学的学科.
- 传染性疾病 传染性疾病
- 腎臟病學 (nephrology) 是一種醫學.
背景情况:
- 对于重症患者的法维皮拉维尔药物动力学数据有限.
- 没有研究研究了中度至重度功能障碍患者的法维皮拉维尔药理学.
研究的目的:
- 为了确定favipiravir的药理动力学在重症COVID-19患者的功能障碍.
- 在这个人群中,将favipiravir的药理动力学与健康成年人的数据进行比较.
主要方法:
- 这是一项描述性研究,涉及7名COVID-19重症患者,估计球膜过率<60毫升/分钟.
- 使用高性能液态染色学 (HPLC) 分析了血液样本.
- 计算了关键的药理动力学参数 (Cmax,tmax,T1/2,AUC0-12h),并与健康受试者的报告数据进行了比较.
主要成果:
- 与健康受试者相比,法维皮拉维尔的Cmax降低 (29.99比64.5微克/毫升),T1/2更长 (5.8比4.8小时).
- 达到最大度 (tmax) 的时间延迟,总暴露 (AUC0-12h) 较低 (192.53与446.09μg/mL).
- 减少的法维皮拉维尔暴露持续到第5天.
结论:
- 患有功能障碍的重症COVID-19患者没有达到预期的favipiravir暴露.
- 较差和延迟的吸收,以及改变的处置,可能解释了暴露的减少.
- 需要进行更多的人口药理动力学和机理学研究,以优化该患者群的法维皮拉维尔剂量.
相关概念视频
01:17Factors Affecting Renal Clearance: Renal Impairment
81
Renal dysfunction significantly impairs the renal clearance of drugs, leading to potential complications in drug therapy. Renal failure, which can be caused by various factors, poses a significant challenge in the elimination of drugs from the body.
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
81
01:11Renal Failure: Dose Adjustments
79
In patients with renal impairment, drugs undergo significant changes in their pharmacokinetics, which require dosage adjustments to ensure safe and effective therapy.
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
79
01:09Factors Affecting Renal Clearance: Drug Distribution and Drug Interactions
125
Renal clearance plays a pivotal role in drug elimination from the body and can be influenced by drug distribution and interactions. Understanding these factors is crucial in pharmacology as they impact the effectiveness and duration of drug therapy.
One important factor is the relationship between renal clearance and the apparent volume of distribution. Renal clearance tends to be inversely proportional to the apparent volume of distribution. Drugs with an extensive distribution volume or those...
One important factor is the relationship between renal clearance and the apparent volume of distribution. Renal clearance tends to be inversely proportional to the apparent volume of distribution. Drugs with an extensive distribution volume or those...
125
01:06Renal Drug Clearance: Overview
181
Renal clearance is a crucial parameter in pharmacokinetics that quantifies the rate at which the kidneys excrete a drug. It represents a constant fraction of the central volume of distribution containing the drug that the kidney eliminates per unit of time.
Renal clearance can be calculated using different methods. One approach is to divide the urinary drug excretion rate by the plasma drug concentration. This method directly measures renal clearance, indicating the kidneys' efficiency in...
Renal clearance can be calculated using different methods. One approach is to divide the urinary drug excretion rate by the plasma drug concentration. This method directly measures renal clearance, indicating the kidneys' efficiency in...
181
01:15Renal Drug Excretion: Overview
145
As primary excretory organs, the kidneys maintain homeostasis by removing waste substances from the bloodstream. They comprise over a million units called nephrons, which serve as the kidney's functional units.
A nephron consists of two primary structures: the renal corpuscle and the renal tubule. The renal corpuscle contains the glomerulus, a network of capillaries where the first step of renal excretion, glomerular filtration, occurs. Blood pressure forces water, ions, and small molecules...
A nephron consists of two primary structures: the renal corpuscle and the renal tubule. The renal corpuscle contains the glomerulus, a network of capillaries where the first step of renal excretion, glomerular filtration, occurs. Blood pressure forces water, ions, and small molecules...
145
01:31Factors Affecting Renal Clearance: Drug's Physicochemical Properties and Plasma Levels
208
Renal clearance of a drug is influenced by various factors, including its physicochemical properties and plasma levels. These factors play a significant role in determining how efficiently the kidneys eliminate a drug.
One important factor is the drug's molecular size. The kidneys readily excrete smaller molecules below 300 Daltons (Da). On the other hand, molecules weighing between 300 and 500 Da are excreted through both urine and bile. Larger molecules above 500 Da tend to be excreted...
One important factor is the drug's molecular size. The kidneys readily excrete smaller molecules below 300 Daltons (Da). On the other hand, molecules weighing between 300 and 500 Da are excreted through both urine and bile. Larger molecules above 500 Da tend to be excreted...
208